Role of Parkin in Familial and Idiopathic Parkinson's Disease
Role of Parkin in Familial and Idiopathic Parkinson's Disease
批准号:
10170978
负责人:
Matthew J Lavoie
金额:
$4.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2021-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by both motor and non-
motor disturbances. While the etiology of the disease is unknown, genetic mutations responsible
for familial forms of PD likely provide critical molecular insights into the underlying mechanisms of idiopathic
disease. Loss-of-function mutations in the ubiquitin E3 ligase parkin are the most common cause of autosomal
recessive PD. Parkin is now widely recognized as a pro-survival protein that possesses broad ranging effects
on mitochondrial biology, and beyond. A more complete comprehension of these functions will will lead to a
firmer understanding of the neurodegenerative process in PD, as well as the identification of new pathways
that may be targeted for disease modification. The long-term goal of our work is to uncover the molecular
machinery responsible for parkin's protective effects in neurons. We propose that both the cytosolic and
mitochondrial-localized pools of parkin play important roles in the maintenance of healthy neurons. This
application will explore the role of cytosolic parkin in its neuro-protective function in human neurons. Using
engineered isogenic and patient based WT and parkin null pluripotent stem cells differentiated to human
neuronal fates, we will uncover the conditions that activate the cytoplasmic pool of parkin. We will identify the
upstream proteins that control parkin activation and its protection against cell death in human neurons. Then,
we will explore the role of BH3 domains in the recognition of an expanding class of putative substrates of
cytoplasmic parkin E3 ligase activity. The pathways found to regulate neuronal parkin function may shed light
on innovative targets for therapeutic intervention to up-regulate parkin activity and induce neuro-protection in
neurologic disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathologic LRRK2 signaling in Familial and Idiopathic Parkinson's Disease
-
批准号:9791022
-
项目类别:
-
资助金额:$45.02万
-
财政年份:2018
-
负责人:Matthew J Lavoie
-
依托单位:
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE
-
批准号:10241552
-
项目类别:
-
资助金额:$35.12万
-
财政年份:2018
-
负责人:Matthew J Lavoie
-
依托单位:
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE
-
批准号:10459599
-
项目类别:
-
资助金额:$35.12万
-
财政年份:2018
-
负责人:Matthew J Lavoie
-
依托单位:
The Activation of LRRK2 by Alpha-Synuclein
-
批准号:8925936
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2014
-
负责人:Matthew J Lavoie
-
依托单位:
The Activation of LRRK2 by Alpha-Synuclein
-
批准号:8823867
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2014
-
负责人:Matthew J Lavoie
-
依托单位:
Regulation of Leucine Rich Repeat Kinase 2 (LRRK2)
-
批准号:8191191
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2011
-
负责人:Matthew J Lavoie
-
依托单位:
Regulation of Leucine Rich Repeat Kinase 2 (LRRK2)
-
批准号:8259427
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2011
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:8451475
-
项目类别:
-
资助金额:$36.93万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:9481344
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:7984298
-
项目类别:
-
资助金额:$38.43万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:8101127
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:8259799
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Genetic Models to Probe the Role of Complex-1 Dysfunction in Neurologic Disease
-
批准号:8055551
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:10197226
-
项目类别:
-
资助金额:$33.36万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:8658153
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Role of Parkin in Familial and Idiopathic Parkinson's Disease
-
批准号:8516663
-
项目类别:
-
资助金额:$5.08万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Genetic Models to Probe the Role of Complex-1 Dysfunction in Neurologic Disease
-
批准号:7870069
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2010
-
负责人:Matthew J Lavoie
-
依托单位:
Protein Aggregation and Modification in Neurodegeneration
-
批准号:7913494
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:Matthew J Lavoie
-
依托单位:
Protein Aggregation and Modification in Neurodegeneration
-
批准号:7371015
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2006
-
负责人:Matthew J Lavoie
-
依托单位:
Protein Aggregation & Modification in Neurodegeneration
-
批准号:7037201
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2006
-
负责人:Matthew J Lavoie
-
依托单位:
国内基金
海外基金
登录
查看更多内容
丙泊酚经PINK1/Parkin通路介导线粒体自噬减轻老年患者髋关节置换术后睡眠剥夺相关心肌损伤的机制研究
-
批准号:2026JJ82522
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周果
-
依托单位:
ATAD3A调控PINK1/PARKIN通路对射血分数保留型心衰中巨噬细胞线粒体自噬和铁代谢稳态的研究
-
批准号:2026JJ82225
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘爱英
-
依托单位:
SMYD2通过上调PYCR1表达调控PINK1/Parkin线粒体自噬通路促进膀胱癌进展的机制研究
-
批准号:2026JJ82057
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈俊杰
-
依托单位:
加味独活寄生合剂通过调控Parkin/PINK1通路介导的线粒体自噬抑制NLRP3炎症小体活化治疗KOA的机制研究
-
批准号:2026JJ81038
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚志贤
-
依托单位:
α7nAChR通过CaMKII激活ANT1/PINK1-Parkin通路调控线粒体自噬抑制小 胶质细胞焦亡改善脓毒症相关性脑病认知障碍的机制
-
批准号:2026JJ81768
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王桥生
-
依托单位:
载BFGF和SDF-1甲壳素水凝胶通过Sirt1/PINK1/parkin信号轴调控线粒体MAMs结构稳定性在SUI中的作用及机制
-
批准号:JCZRLH202602139
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
不同血硒浓度通过Sirt1/PINK1/parkin信号轴调控MAMs结构稳定性在SUI中的作用及机制
-
批准号:JCZRLH202600274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
槲皮素通过调节Pink1/Parkin介导的小胶质细胞线粒体自噬保护新生大鼠脑白质损伤机制的研究
-
批准号:JCZRLH202600801
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于PINK1/Parkin介导的线粒体自噬和抑制NLRP3炎症小体激活探讨柔肝通络汤治疗帕金森病的机制研究
-
批准号:2026JJ82256
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:范建虎
-
依托单位:
Maresin-1通过调控PINK1/Parkin介导的线粒体自噬通路减轻脓毒症急性肾损伤的机制研究
-
批准号:2026JJ82439
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:夏凤强
-
依托单位: